Tratamiento con inmunoglobulina G subcutánea en enfermos con inmunodeficiencias primarias: resultados preliminares del estudio multicentrico cubano

Macías-Abraham, Consuelo; Sánchez Segura, Miriam; Insua Arregui, Concepción; García Nieblas, María del Carmen; Hernández Flores, Gueimy; Arce Hernández, Ada; Merlín Linares, Julio César; Martínez Triana, Raúl.
Rev. cuba. hematol. inmunol. hemoter ; 32(3): 364-374, jul.-set. 2016. tab
Artigo em Espanhol | LILACS | ID: biblio-844884

Documentos relacionados

  1. Tratamiento con inmunoglobulina G subcutánea en enfermos con inmunodeficiencias primarias: resultados preliminares del estudio multicentrico cubano
  2. The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency.
  3. Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: A 2-year real-life experience.
  4. Relationships between bronchiectasis and time to achieving target trough immunoglobulin G levels in patients with common variable immunodeficiency.
  5. A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency.
  6. Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiency.
  7. Challenges for gene editing in common variable immunodeficiency disorders: Current and future prospects.
  8. Clinical and laboratory evaluation of periodically monitored Turkish children with IgG subclass deficiencies.
  9. Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement.
  10. Effect of intravenous immunoglobulins on in vitro immunoglobulin formation in patients with antibody immunodeficiency.